Fundz

DecisionRx Appoints Michael Tilton as Chief Growth Officer to Expand Commercialization Activities

PRIVATEOct 29, 2024

Position

Chief Growth Officer

Company

DecisionRx, Inc.

Michael Tilton
United StatesHealth CareInsurance

Description

DecisionRx, Inc. has appointed Michael Tilton, a seasoned healthcare executive, as Chief Growth Officer. Tilton will lead the company’s activities to expand commercialization of the DecisionRx Medication Therapy Optimization (MTO) platform, with the aim of accelerating adoption by more organizations to ultimately benefit more physicians and patients.

Quick answer

DecisionRx Appoints Michael Tilton as Chief Growth Officer to Expand Commercialization Activities (October 29, 2024). DecisionRx, Inc. is based in United States.

Who is the new Chief Growth Officer at DecisionRx, Inc?
DecisionRx, Inc. named Michael Tilton Chief Growth Officer, announced October 29, 2024.
What did DecisionRx, Inc. announce on October 29, 2024?
DecisionRx, Inc. has appointed Michael Tilton, a seasoned healthcare executive, as Chief Growth Officer. Tilton will lead the company’s activities to expand commercialization of the DecisionRx Medication Therapy Optimization (MTO) platform, with the aim of accelerating adoption by more organizations to ultimately benefit more physicians and patients.
What does DecisionRx, Inc. do?
DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping physicians optimize prescribing decisions for their patients.
Where is DecisionRx, Inc. based?
DecisionRx, Inc. is based in United States.
Which similar companies made leadership changes around the same time?
Blue Shield of California (October 28, 2024), Aflac Incorporated (October 30, 2024), Ethos (November 7, 2024) and Digital Owl (November 12, 2024) also announced leadership changes within 45 days of DecisionRx, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Insurance and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at DecisionRx, Inc., and when

A new leader at DecisionRx, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day DecisionRx, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DecisionRx, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DecisionRx, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DecisionRx, Inc.

Location

United States

About

DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping physicians optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients’ behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data-science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce total annualized cost of care by $3,600 for Medicare patients and $1,200 for patients under age 65.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DecisionRx, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for DecisionRx, Inc.'s next move

Learn about Strategic plan

DecisionRx, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.